MeadWestvaco Corp. (NYSE: MWV), a global leader in packaging and packaging solutions, today announced the commercial availability of the Avive® Multimed system, a software-based solution that establishes a pharmacy home, synchronizes medication regimens, improves adherence, supports reimbursement for services including medication therapy management and helps dramatically improve CMS Star Ratings performance. Avive is unique among pharmacy solutions because it offers multiple benefits in one seamless, proprietary software system.
Avive® is a software-based pharmacy system with proven benefits across patient, payer and provider needs that increases medication adherence, pharmacy efficiency and CMS Star Ratings (Photo: Business Wire)
MWV Healthcare and its partner, LTCPCMS, Inc., developed the Avive system to decrease the complexities of poly-pharmacy. Avive is designed to provide pharmacists and health care management personnel with software tools and workflow to create synchronized, personalized medication regimens. These regimens drive patient adherence by accommodating their input and activities of daily living. The Avive solution is supported by pending patents.
“We have successfully used the Avive solution in a test environment for nearly two years on a very adherence-challenged patient population with multiple chronic diseases,” said Tom Grinnan, senior director, Healthcare Innovation & EU Adherence, MWV. “The data has shown that Avive is distinctly successful in achieving a full pharmacy home and improving refill rates. We are now ready to license this unique program to pharmacy partners, developers and PBMs.”
Avive addresses the growing number of people in the United States suffering from co-morbidities who are taking an increasing number of medications, prescribed by a number of physicians and purchased from a myriad of pharmacies. Research shows that by synchronizing these medications with one pharmacy home, patients can experience better health outcomes, health-related expenses are lowered and refill rates rise dramatically.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts